Assessment and management of cancer-related fatigue in adults (Q35207871)

7 August 2017

1 reference

title

Assessment and management of cancer-related fatigue in adults (English)

1 reference

7 August 2017

Fannie Gaston-Johansson

series ordinal

3

object named as

Fannie Gaston-Johansson

1 reference

7 August 2017

Karin Ahlberg

1

1 reference

7 August 2017

Tor Ekman

series ordinal

2

1 reference

7 August 2017

Victoria Mock

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

362

1 reference

7 August 2017

9384

1 reference

7 August 2017

640-650

1 reference

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

The biologic basis of fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue in patients with prostate cancer receiving hormone therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Patterns of self-care needs and interventions related to biologic response modifier therapy: fatigue as a model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue in advanced cancer: a prospective controlled cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

A qualitative study to explore the experience of fatigue in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Prevalence of anemia in cancer patients undergoing radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Chemotherapy-induced anemia in adults: incidence and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue during preoperative chemoradiation for resectable rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Quality of life changes during conformal radiation therapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Frequency and correlates of fatigue in lung cancer patients receiving radiation therapy: implications for management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

The role of cytokines in cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

The effect of indomethacin on food and water intake, motor activity and survival in tumour-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

TNF-alpha and chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Serum evaluation of interleukin 6 in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Serum Soluble Interleukin-2 Receptor Levels in Patients with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

High level of fatigue in lymphoma patients treated with high dose therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Cytokines in endocrinology: their roles in health and in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue, pain, and depression in pre-autotransplant breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue and its associated factors in ambulatory cancer patients: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue and quality of life outcomes of exercise during cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Psychometric testing of fatigue instruments for use with cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

A fatigue clinic in a comprehensive cancer center: design and experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

The health diary: an examination of its use as a data collection method

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue management: evidence and guidelines for practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Additional construct validity of the Schwartz Cancer Fatigue Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Assessment and epidemiologic issues related to fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Reducing the negative impact of radiation therapy on functional status.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Self-regulation theory and coping with physical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Rating the quality of evidence for clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Aerobic exercise as therapy for cancer fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Fatigue mediates the effects of exercise on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Daily fatigue patterns and effect of exercise in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Physical exercise and quality of life following cancer diagnosis: a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Exercise in the rehabilitation of breast cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

1 reference

7 January 2021

Feasibilty of a sleep intervention during adjuvant breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

A pilot study examining energy conservation for cancer treatment-related fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Psychotherapy during radiotherapy: effects on emotional and physical distress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Group support for patients with metastatic cancer. A randomized outcome study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Pain and fatigue management: results of a nursing randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Attention and symptom distress in women with and without breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Palliative uses of methylphenidate in patients with cancer: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

Preparing patients for cancer chemotherapy: effect of coping preparation and relaxation interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914186-4

7 January 2021

10.1016/S0140-6736(03)14186-4

Identifiers

DOI

1 reference

7 August 2017

1 reference